Financial Results - Standalone (All amounts in ₹ lakhs)
Quarterly Performance (Q2 FY2026)
- Revenue from operations (net): ₹192.47
- Other income: Not separately quantified in quarterly breakdown
- Total Income: ₹192.47
- Profit before tax: ₹47.21
- Tax expense: ₹11.07 (Current tax: ₹11.56, Deferred tax: ₹-0.49)
- Profit for the quarter: ₹36.13
- Other Comprehensive Income: ₹0.47
- Total Comprehensive Income: ₹36.60
- Basic and Diluted EPS: ₹0.18
Half Yearly Performance (H1 FY2026)
- Revenue from operations (net): ₹385.79
- Other income: Not separately quantified in half yearly breakdown
- Total Income: ₹385.79
- Profit before tax: ₹92.30
- Tax expense: ₹26.06 (Current tax: ₹23.38, Deferred tax: ₹3.68)
- Profit for the period: ₹65.24
- Other Comprehensive Income: ₹0.37
- Total Comprehensive Income: ₹65.61
- Basic and Diluted EPS: ₹0.32
Comparative Figures (Previous Periods)
- Q2 FY2025: Total Income ₹201.74 lakhs, Profit ₹31.04 lakhs
- H1 FY2025: Total Income ₹388.22 lakhs, Profit ₹64.77 lakhs
- FY2025: Total Income ₹755.14 lakhs, Profit ₹137.98 lakhs
Financial Results - Consolidated (All amounts in ₹ lakhs)
Quarterly Performance (Q2 FY2026)
- Revenue from operations (net): ₹315.07
- Other income: ₹9.20
- Total Income: ₹324.27
- Profit before tax: ₹74.88
- Tax expense: ₹11.03 (Current tax: ₹11.56, Deferred tax: ₹-0.53)
- Profit for the quarter: ₹63.85
- Other Comprehensive Income: ₹0.64
- Total Comprehensive Income: ₹64.49
- Basic and Diluted EPS: ₹0.32
Half Yearly Performance (H1 FY2026)
- Revenue from operations (net): ₹580.46
- Other income: ₹18.94
- Total Income: ₹599.40
- Profit before tax: ₹116.94
- Tax expense: ₹27.02 (Current tax: ₹23.38, Deferred tax: ₹3.64)
- Profit for the period: ₹89.02
- Other Comprehensive Income: ₹1.37
- Total Comprehensive Income: ₹90.39
- Basic and Diluted EPS: ₹0.44
Consolidated Entity Composition
- Holding Company: Tejnaksh Healthcare Limited
- Subsidiary: Tej Vedaant Healthcare Private Limited
Balance Sheet Highlights - Standalone (as of September 30, 2026)
- Total Assets: ₹3,003.54 lakhs
- Non-current assets: ₹2,578.04 lakhs
- Current assets: ₹425.50 lakhs
- Total Equity: ₹2,745.16 lakhs
- Equity share capital: ₹1,015.68 lakhs
- Other equity: ₹1,729.48 lakhs
- Total Liabilities: ₹258.38 lakhs
Balance Sheet Highlights - Consolidated (as of September 30, 2026)
- Total Assets: ₹3,130.05 lakhs
- Non-current assets: ₹2,582.45 lakhs
- Current assets: ₹547.60 lakhs
- Total Equity: ₹2,854.67 lakhs
- Equity attributable to owners: ₹2,799.30 lakhs
- Non-controlling interest: ₹55.37 lakhs
- Total Liabilities: ₹275.38 lakhs
Cash Flow Statements
Standalone Cash Flows (H1 FY2026)
- Net cash from operating activities: ₹-12.59 lakhs
- Net cash used in investing activities: ₹-21.63 lakhs
- Net cash used in financing activities: ₹-7.87 lakhs
- Net decrease in cash: ₹-42.09 lakhs
- Cash and cash equivalents at end: ₹136.46 lakhs
Consolidated Cash Flows (H1 FY2026)
- Net cash from operating activities: ₹10.56 lakhs
- Net cash used in investing activities: ₹-14.97 lakhs
- Net cash used in financing activities: ₹-123.80 lakhs
- Net decrease in cash: ₹-128.21 lakhs
- Cash and cash equivalents at end: ₹183.83 lakhs
Auditor Review
Maheshwari & Co., Chartered Accountants (Firm Registration No.: 105834W) conducted limited review of both standalone and consolidated financial results. They issued unmodified conclusions stating nothing came to their attention causing belief that the statements contain material misstatements.
Important Notes
1. Figures for Q2 September 2026 represent balancing figures between H1 September 2026 and published Q1 June 2026 figures
2. Results prepared in accordance with Ind AS 34 - Interim Financial Reporting
3. Company operates in single business segment: "Medical and Healthcare Services"
4. Previous period figures have been regrouped for comparability
5. Paid-up equity share capital: ₹1,015.68 lakhs (face value ₹5 each)